NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $404,388 | +91.6% | 23,607 | +74.9% | 0.00% | – |
| Q1 2024 | $211,005 | -92.8% | 13,500 | -72.3% | 0.00% | -100.0% |
| Q1 2023 | $2,931,645 | +1045.2% | 48,747 | +4120.5% | 0.01% | +1300.0% |
| Q2 2021 | $256,000 | -97.9% | 1,155 | -98.8% | 0.00% | -96.7% |
| Q1 2021 | $12,275,000 | -67.2% | 92,866 | -57.1% | 0.03% | -61.0% |
| Q4 2020 | $37,446,000 | -28.9% | 216,400 | -54.3% | 0.08% | -40.8% |
| Q3 2020 | $52,694,000 | +514.5% | 473,400 | +227.4% | 0.13% | +333.3% |
| Q2 2020 | $8,575,000 | +65.4% | 144,602 | +87.9% | 0.03% | -3.2% |
| Q1 2020 | $5,184,000 | -40.7% | 76,970 | -25.8% | 0.03% | -31.1% |
| Q4 2019 | $8,747,000 | +1883.4% | 103,799 | +1659.3% | 0.04% | +1400.0% |
| Q3 2019 | $441,000 | -62.1% | 5,900 | -73.4% | 0.00% | -40.0% |
| Q3 2018 | $1,163,000 | – | 22,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |